James R. Rogers

Merck & Co., Inc., Rahway, NJ, USA (United States)

PsychologyMedicineHealth ProfessionsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness”.

A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine Effectiveness

medRxiv(2021)10.1101/2021.10.05.21264583

N/A

0DataRank · unranked

50 citations

Junghwan Lee, Casey Ta, Ali Soroush, James R. Rogers, Jae Hyun Kim +4 more

Deep learning for rare disease: A scoping review

Journal of Biomedical Informatics(2022)10.1016/j.jbi.2022.104227

N/A

0DataRank · unranked

62 citations

Cong Liu, Junyoung Kim, Zhehuan Chen, Yingcheng Sun, James R. Rogers +3 more

Deep Learning for Rare Disease: A Scoping Review

medRxiv(2022)10.1101/2022.06.29.22277046

N/A

0DataRank · unranked

5 citations

Cong Liu, Junyoung Kim, Zhehuan Chen, Yingcheng Sun, James R. Rogers +3 more